Mitoxantrone
Showing 1 - 25 of 383
Relapsing Multiple Sclerosis Trial in Beijing (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Relapsing Multiple Sclerosis
- Mitoxantrone Hydrochloride Liposome Injection
-
Beijing, Beijing, ChinaXuanwu Hospital Capital Medical University
Aug 9, 2022
Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
Sep 20, 2022
Lymphoma, Solid Tumors Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome)
Recruiting
- Lymphoma, Solid Tumors
- Mitoxantrone Hydrochloride Liposome
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 14, 2022
Advanced Solid Tumor Trial (Mitoxantrone Hydrochloride Liposome injection, Capecitabine, Albumin-paclitaxel)
Not yet recruiting
- Advanced Solid Tumor
- Mitoxantrone Hydrochloride Liposome injection
- +2 more
- (no location specified)
Apr 18, 2022
Recurrent Metastatic Nasopharyngeal Carcinoma Trial (Mitoxantrone HCl liposome injection, Capecitabine)
Not yet recruiting
- Recurrent Metastatic Nasopharyngeal Carcinoma
- Mitoxantrone hydrochloride liposome injection
- Capecitabine
- (no location specified)
Jan 29, 2023
Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial (Mitoxantrone Hydrochloride Liposome)
Not yet recruiting
- Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Mitoxantrone Hydrochloride Liposome
- (no location specified)
Apr 19, 2022
T Cell Lymphoma Trial (Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen)
Not yet recruiting
- T Cell Lymphoma
- Cidapenem combined with azacitidine and mitoxantrone liposome (CAM) regimen
- (no location specified)
Mar 6, 2023
Relapsed or Refractory Multiple Myeloma Trial in Beijing (Mitoxantrone Hydrochloride Liposome injection, Bortezomib for
Recruiting
- Relapsed or Refractory Multiple Myeloma
- Mitoxantrone Hydrochloride Liposome injection
- +2 more
-
Beijing, Beijing, ChinaBeijing Chaoyang Hospital, Capital Medical University
Jan 16, 2022
Recurrent/Refractory Lymphoma Trial in Guiyang (Mitoxantrone Hydrochloride Liposome Injection)
Completed
- Recurrent/Refractory Lymphoma
- Mitoxantrone Hydrochloride Liposome Injection
-
Guiyang, Guizhou, ChinaGuizhou Cancer Hospita
Dec 12, 2021
Diffuse Large B-cell Lymphoma Trial in Wuhan (Mitoxantrone Hydrochloride Liposome, Rituximab, Lenalidomide)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Mitoxantrone Hydrochloride Liposome
- +2 more
-
Wuhan, Hubei, ChinaDepartment of Hematology Tongji Hospital, Tongji Medical College
Oct 7, 2022
Peripheral T Cell Lymphoma Trial in Zhejiang (Mitoxantrone liposome?Chidamide?Azacitidine)
Recruiting
- Peripheral T Cell Lymphoma
- Mitoxantrone liposome、Chidamide、Azacitidine
-
Zhejiang, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Aug 9, 2022
Advanced Pancreatic Cancer Trial (Mitoxantrone Hydrochloride Liposome injection)
Not yet recruiting
- Advanced Pancreatic Cancer
- Mitoxantrone Hydrochloride Liposome injection
- (no location specified)
Oct 19, 2021
Treatment, Peripheral T-cell Lymphoma Trial in Beijing (liposomal mitoxantrone HCl, gemcitabine, dexamethasone, and cisplatin)
Recruiting
- Treatment
- Peripheral T-cell Lymphoma
- liposomal mitoxantrone hydrochloride, gemcitabine, dexamethasone, and cisplatin
-
Beijing, China
- +4 more
Jun 28, 2022
Non Hodgkin Lymphoma Trial (Liposomal Mitoxantrone Hydrochloride dose level 1, Liposomal Mitoxantrone Hydrochloride dose level
Not yet recruiting
- Non Hodgkin Lymphoma
- Liposomal Mitoxantrone Hydrochloride dose level 1
- +6 more
- (no location specified)
Mar 17, 2022
NK-T-Cell Lymphoma, Extranodal Trial (Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride
Not yet recruiting
- NK-T-Cell Lymphoma, Extranodal
- Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) regimen
- (no location specified)
Mar 7, 2023
Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)
Recruiting
- Acute Myeloid Leukemia
- mitoxantrone + etoposide + gemtuzumab ozogamicin
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 9, 2022
Advanced Malignant Tumor Trial (Mitoxantrone Hydrochloride Liposome)
Not yet recruiting
- Advanced Malignant Tumor
- Mitoxantrone Hydrochloride Liposome
- (no location specified)
Oct 9, 2021
Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)
Recruiting
- Prostate Cancer Patients
- Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
-
Qingdao, Shandong, China
- +1 more
May 3, 2022
Extranodal Natural Killer T Cell Lymphoma Trial in China (Tislelizumab combined with Liposomal mitoxantrone HCl, Maintenance of
Recruiting
- Extranodal Natural Killer T Cell Lymphoma
- Tislelizumab combined with Liposomal mitoxantrone hydrochloride
- Maintenance of tislelizumab
-
Beijing, China
- +5 more
Jul 15, 2022
Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Gilteritinib 40 MG Oral Tablet
- +4 more
- (no location specified)
Apr 8, 2022
Treatment-naïve, Peripheral T Cell Lymphoma Trial in Guangzhou (Dose-finding stage: Liposomal mitoxantrone HCl,
Recruiting
- Treatment-naïve
- Peripheral T Cell Lymphoma
- Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
- Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 26, 2021
Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML) Trial in Guiyang (Mitoxantrone Hydrochloride liposome
Not yet recruiting
- Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Mitoxantrone Hydrochloride liposome injection
- Cytarabine (LoDAC)
-
Guiyang, Guizhou, ChinaThe Affiliated Hospital of Guizhou Medical University
Oct 19, 2021
Advanced Solid Tumors Trial in Baoding (Mitoxantrone Hydrochloride Liposome injection)
Not yet recruiting
- Advanced Solid Tumors
- Mitoxantrone Hydrochloride Liposome injection
-
Baoding, Hebei, ChinaAffiliated Hospital of Hebei University
Jun 4, 2021
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoblastic Lymphoma Trial in Valhalla, Charlotte (Clofarabine,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Clofarabine
- Mitoxantrone
-
Valhalla, New York
- +1 more
Oct 29, 2021
Unresectable or Metastatic Bone and Soft Tissue Sarcoma Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Unresectable or Metastatic Bone and Soft Tissue Sarcoma
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
May 20, 2021